Mutations or dysregulation of ARRDC3 can affect these pathways and have been linked to various disorders, including obesity, cancer, and metabolic syndromes (Batista et al., 2020; Wedegaertner et al., 2022). Here, ARRDC3 is linked to obesity due to melanocortin 4 receptor deficiency.